The Hydropothecary Corporation (“THCX” or the “Company”) (TSXV:THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.
The kosher certification, includes Decarb, the ready-to-consume activated marijuana powder product line, Elixir cannabis peppermint oil and the H2 line of milled products.
“Kosher certification is important to Hydropothecary because it reflects our emphasis on rigorous testing, independent third-party oversight and our focus on easy-to-use product innovations. As the only medical marijuana company in Canada with current kosher-certified processed products, we take great pride in having the support of the Council for Kashrut,” said Hydropothecary CEO and co-founder, Sebastien St-Louis.
The announcement of the certification, by Vaad HaKashrut director, Rabbi Levy Teitlebaum, comes just in time for Rosh Hashanah, on September 20.
“Kosher certification is something that is relied upon by many people, including vegans, vegetarians and people who are careful about what they consume, as a symbol of trust. What this certification shows is the value placed on proper etiquette for kosher and for being able to care for people. That is a beautiful harmony between the Council and Hydropothecary,” Rabbi Teitlebaum said.
Obtaining kosher certification requires several components, including an audit of cleaning protocols, kosher compliance review and on-site inspections throughout the year.
“This is a rigorous, independent, third-party certification process that goes from A to Z. Hydropothecary’s products not only qualify, but certification is gladly given because it’s important for what’s needed in this new sector,” said Rabbi Teitlebaum.
About The Hydropothecary Corporation
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides sungrown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary’s branding, cannabis product offering, patient service standards and product pricing are consistent with THCX’s positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.

FAQs About Kosher Certification and Medical Marijuana
Rabbi Levy Teitlebaum
Ottawa Vaad HaKashrut


What does kosher certification mean?
“Kosher certification is given to foods and consumed items that conform to kashrut or Jewish dietary law. This applies to processed foods, including plant products and animal products. Kosher ensures that what we are ingesting has been reviewed and conforms to dietary and religious needs.”
How will those taking medical marijuana know a product is kosher certified?
“Our symbol will appear on the label of every Hydropothecary product that is kosher certified. Clients can also obtain a Letter of Kosher Certification from Hydropothecary.”
Why is the advantage of kosher certification for medical marijuana products?
“As with the purchase of all consumable products, clients searching for kosher certification will know that their products adhere to the highest standards of kosher purity.”
When legalization of marijuana comes into effect in July, 2018, how will that affect kosher certification?
“Medical products required for health and wellbeing are eligible for kosher certification. With legalization of marijuana for recreational use, however, we will have to consider the ethics of using a product simply for enjoyment.”
Image Available: http://www.marketwire.com/library/MwGo/2017/9/19/11G145625/Images/Vaad_Hakashrut_logo-6eb137dc3dcba2d4903be65e1a1ca019.jpg

CONTACT INFORMATION

Source: m.marketwired.com

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less